keyword
https://read.qxmd.com/read/38471493/focus-on-upper-urinary-tract-stones-combined-with-parenchymal-infiltrative-renal-pelvis-cancer
#21
Yue Zhang, Ying Ke, Ai-Xin Qiu, Bo Yang, Chen Shen, Li-Jie Wen, Xiao-Long Xu, Yang Yu, Wei Wang
INTRODUCTION: Upper urinary tract stones combined with parenchymal infiltrative renal pelvic cancer is challenging to detect on imaging, and to evaluate the differential diagnosis. CASE PRESENTATION: The symptoms and diagnoses in three cases of parenchymal infiltrative renal pelvic cancer and upper urinary tract stones that occurred between June 2019 and June 2022 were reviewed. Primary symptoms of lumbar discomfort and hemoturia were evident in all three patients...
March 12, 2024: Kidney & Blood Pressure Research
https://read.qxmd.com/read/38468557/postoperative-outcomes-and-analgesic-requirements-of-single-port-vs-multi-port-robotic-assisted-radical-cystectomy
#22
JOURNAL ARTICLE
Andrew Fang, Omar Hayek, John Kaylor, Charles Peyton, James E Ferguson, Jeffrey Nix, Soroush Rais-Bahrami
OBJECTIVE: To compare outcomes in patients undergoing robotic-assisted radical cystectomy (RARC) with urinary diversion for bladder cancer with either the single-port (SP) or multi-port (MP) robotic platform. METHODS: All patients who underwent SP and MP RARC at our institution between January 2018 and January 2023 were retrospectively reviewed. Postoperative analgesia was administered by a department-wide narcotic stewardship protocol, and inpatient and outpatient narcotic use was tracked...
March 12, 2024: Journal of Endourology
https://read.qxmd.com/read/38466862/adult-patients-treated-for-bladder-exstrophy-at-a-young-age-what-are-their-current-demands
#23
JOURNAL ARTICLE
Amélie Bazinet, Alya Filfilan, Nawel Mokhtari, Louis Lenfant, Alaa Elghoneimi, Emmanuel Chartier-Kastler
INTRODUCTION: Bladder exstrophy-epispadias complex is a rare condition that necessitates numerous surgical procedures during a patient's youth to achieve adequate urine storage and continence. This study aimed to identify the specific needs and functional challenges faced by adults who underwent pediatric bladder exstrophy reconstructions and assessing the management of these issues in an adult population. METHODS: A retrospective chart review was conducted for all bladder exstrophy complex patients who underwent surgery at a young age and were subsequently referred to our center between 2005 and 2020...
March 1, 2024: Canadian Urological Association Journal
https://read.qxmd.com/read/38466217/long-term-survival-after-volatile-or-propofol-general-anesthesia-for-bladder-cancer-surgery-a-retrospective-national-registry-cohort-study
#24
JOURNAL ARTICLE
Mats Enlund, Hampus Hållberg, Anders Berglund, Amir Sherif, Anna Enlund, Leif Bergkvist
BACKGROUND: Prospective interventional trials and retrospective observational analyses provide conflicting evidence regarding the relationship between propofol versus inhaled volatile general anesthesia and long-term survival after cancer surgery. In specific, bladder cancer surgery lacks prospective clinical trial evidence. METHODS: Data on bladder cancer surgery performed under general anesthesia between 2014 and 2021 from The National Quality Registry for Urinary Tract and Bladder Cancer and the Swedish Perioperative Registry were record-linked...
March 11, 2024: Anesthesiology
https://read.qxmd.com/read/38456541/safety-and-quality-of-cystectomy-and-pelvic-lymph-node-dissection-after-neoadjuvant-durvalumab-and-cisplatin-gemcitabine
#25
JOURNAL ARTICLE
Luca Afferi, Martin Spahn, Stefanie Hayoz, Räto T Strebel, Sacha I Rothschild, Helge Seifert, Berna C Özdemir, Bernhard Kiss, Philipp Maletzki, Daniel Engeler, Gregory Wirth, Boris Hadaschik, Ilaria Lucca, Hubert John, Andreas Sauer, Michael Müntener, Lukas Bubendorf, Martina Schneider, Jana Musilova, Ulf Petrausch, Richard Cathomas
OBJECTIVE: To report on the surgical safety and quality of pelvic lymph node dissection (PLND) in patients treated with radical cystectomy (RC) and PLND for muscle-invasive bladder cancer (MIBC) after neoadjuvant chemo-immunotherapy. PATIENTS AND METHODS: The Swiss Group for Clinical Cancer Research (SAKK) 06/17 was an open-label single-arm phase II trial including 61 cisplatin-fit patients with clinical stage (c)T2-T4a cN0-1 operable urothelial MIBC or upper urinary tract cancer...
March 8, 2024: BJU International
https://read.qxmd.com/read/38450257/prospective-evaluation-of-sexual-health-following-radical-cystectomy-due-to-bladder-cancer
#26
JOURNAL ARTICLE
Julia Nolting, Romy Nitzsche, Bernhard Kiss, Oliver W Hakenberg, Laila Schneidewind
BACKGROUND: There is a lack of data concerning sexual health following open radical cystectomy (RC), especially in elderly patients and women. AIM: To describe sexual health and its impact on general health as well as survival in patients undergoing standard open RC for the treatment of bladder cancer (BC). Due to limited data, subgroup analysis for elderly patients and women was performed. METHODS: A prospective noninterventional clinical study was performed evaluating sexual health in RC with any kind of urinary diversion due to BC with a follow-up of 12 months after RC...
February 2024: Sexual Medicine
https://read.qxmd.com/read/38443295/linear-muscle-segmentation-for-metastatic-renal-cell-carcinoma-changes-in-clinic-friendly-estimation-predict-survival-following-cytoreductive-nephrectomy
#27
JOURNAL ARTICLE
Edouard H Nicaise, Benjamin N Schmeusser, Adil Ali, Eric Midenberg, Arnold R Palacios, Blaise Hartsoe, Ethan Kearns, Sriram Ambadi, Dattatraya H Patil, Shreyas S Joshi, Vikram M Narayan, Sarah P Psutka, Bassel Nazha, Jacqueline T Brown, Kenneth Ogan, Mehmet A Bilen, Viraj A Master
INTRODUCTION: Baseline sarcopenia and postoperative changes in muscle mass are independently associated with overall survival (OS) in patients with metastatic renal cell carcinoma (mRCC) undergoing cytoreductive nephrectomy (CN). Here we examine the relationships between preoperative (baseline), postoperative changes in muscle quantity, and survival outcomes following CN as determined by linear segmentation, a clinic-friendly tool that rapidly estimates muscle mass. MATERIALS AND METHODS: Our nephrectomy database was reviewed for patients with metastatic disease who underwent CN for RCC...
February 16, 2024: Clinical Genitourinary Cancer
https://read.qxmd.com/read/38442451/clinical-profile-and-outcomes-of-carcinoma-penis-patients-receiving-systemic-therapy-at-an-indian-tertiary-care-center-a-retrospective-observational-study
#28
JOURNAL ARTICLE
Vanita Noronha, Venkatesh Kapu, Amit Joshi, Nandini Menon, Ajaykumar Singh, Gagan Prakash, Santosh Menon, Nilesh Sable, Vedang Murthy, Mahendra Pal, Amandeep Arora, Sravan Kumar, Shripad Banavali, Kumar Prabhash
BACKGROUND: Penile cancer is a rare malignancy with scant data on the impact of systemic therapy on outcomes. METHODS: Retrospective observational study of patients with a histological diagnosis of carcinoma penis treated with systemic therapy at the Tata Memorial Centre (Mumbai, India) between August 2010 and February 2018. Primary objective was overall survival (OS); secondary objectives included assessment of clinical characteristics, treatment approaches, and toxicity profiles...
February 7, 2024: Clinical Genitourinary Cancer
https://read.qxmd.com/read/38426380/hydrogel-a-new-material-for-intravesical-drug-delivery-after-bladder-cancer-surgery
#29
REVIEW
Yalong Wu, Xinquan Gu, Xiaoxi Chen, Yongliang Cui, Wei Jiang, Bin Liu
The standard treatment for non-muscle invasive bladder cancer (NMIBC) is transurethral resection of bladder tumor (TURBT). However, this procedure may miss small lesions or incompletely remove them, resulting in cancer recurrence or progression. As a result, intravesical instillation of chemotherapy or immunotherapy drugs is often used as an adjunctive treatment after TURBT to prevent cancer recurrence. In the traditional method, drugs are instilled into the patient's bladder through a urinary catheter under sterile conditions...
March 1, 2024: Journal of Materials Chemistry. B, Materials for Biology and Medicine
https://read.qxmd.com/read/38423930/value-of-cystatin-c-based-sarcopenia-index-in-patients-undergoing-surgery-for-renal-tumors
#30
JOURNAL ARTICLE
Shugo Yajima, Yasukazu Nakanishi, Ryo Andy Ogasawara, Naoki Imasato, Kohei Hirose, Sao Katsumura, Madoka Kataoka, Hitoshi Masuda
INTRODUCTION: Sarcopenia is a condition of low muscle strength and quantity, severe if low physical performances. The sarcopenia index (SI), calculated by blood levels of creatinine and cystatin C, had been reported to be correlated with skeletal muscle mass and is a potential simple screening tool for sarcopenia. We hypothesized that patients with a low SI, meaning low muscle mass, would have an inflated estimated glomerular filtration rate (eGFR) value based on serum creatinine levels...
February 9, 2024: Clinical Genitourinary Cancer
https://read.qxmd.com/read/38423578/management-conundrum-in-a-case-of-renal-cell-cancer-rcc-on-dual-antiplatelet-therapy-dapt-for-recently-placed-coronary-drug-eluting-stent-des
#31
JOURNAL ARTICLE
Rudra Prasad Ghorai, Sridhar Panaiyadiyan, Prabhjot Singh, Brusabhanu Nayak
A man in his 50s presented in an emergency with breathlessness and chest discomfort. On evaluation, he was diagnosed with coronary artery disease, with more than 80% narrowing of the right coronary and left circumflex arteries. The patient underwent percutaneous coronary intervention and was started on dual antiplatelet (DAPT) therapy. After starting DAPT, the patient developed gross haematuria with a drop in haematocrit. Further evaluation revealed a left renal mass with urinary bladder clots. Because of the risk of stent thrombosis on stopping DAPT, radical nephrectomy was deferred, and the patient underwent left renal artery angioembolisation and bladder clot evacuation...
February 29, 2024: BMJ Case Reports
https://read.qxmd.com/read/38418597/-palliative-surgery-for-metastatic-prostate-cancer
#32
REVIEW
Axel Heidenreich, Christian Bach, David Pfister
Androgen deprivation in combination with novel hormonal agents, docetaxel, or in combination with abiraterone/prednisone plus docetaxel or darolutamid plus docetaxel represent the standard therapeutic approach in metastatic hormone-sensitive prostate cancer (mHSPC). Patients with low-risk prostate cancer also benefit from additional radiation therapy or radical prostatectomy in terms of progression-free and overall survival. Despite favorable response rates, basically all patients will develop castration resistant prostate cancer (CRPC) within 2...
February 28, 2024: Urologie
https://read.qxmd.com/read/38418269/functional-and-oncologic-outcomes-of-prostate-capsule-sparing-radical-cystectomy-a-systematic-review-and-meta-analysis
#33
REVIEW
Christopher P Dall, James B Mason, Charlotte C Goldman, Grant Fabrizio, Emily C Alagha, Jiling Chou, Keith J Kowalczyk, Piyush K Agarwal, Lambros Stamatakis, Ross E Krasnow
Radical cystectomy (RC) is the gold standard treatment for patients with organ-confined bladder cancer. However, despite the success of this treatment, many men who undergo orthotopic neobladder substitution develop significant erectile dysfunction and urinary symptoms, including daytime and nighttime urinary incontinence. Prostate-capsule-sparing radical cystectomy (PCS-RC) with orthotopic neobladder (ONB) has been described in the literature as a surgical technique to improve functional outcomes in appropriately selected patients...
February 27, 2024: Urologic Oncology
https://read.qxmd.com/read/38413496/systematic-review-comparing-uretero-enteric-stricture-rates-between-open-cystectomy-with-ileal-conduit-robotic-cystectomy-with-extra-corporeal-ileal-conduit-and-robotic-cystectomy-with-intra-corporeal-ileal-conduit-formation
#34
REVIEW
Daniel P McNicholas, Omar El-Taji, Zain Siddiqui, Vishwanath Hanchanale
Cystectomy is the gold standard treatment for muscle invasive bladder cancer. Robotic cystectomy has become increasingly popular owing to quicker post- operative recovery, less blood loss and less post-operative pain. Urinary diversion is increasingly being performed with an intracorporeal technique. Uretero-enteric strictures (UES) cause significant morbidity for patients. UES for open cystectomy is 3-10%, but the range is much wider (0-25%) for robotic surgery. We aim to perform systematic review for studies comparing all 3 techniques, to assess for ureteric stricture rates...
February 28, 2024: Journal of Robotic Surgery
https://read.qxmd.com/read/38410231/postoperative-complications-and-determinant-of-selecting-non-intracorporeal-urinary-diversion-in-patients-undergoing-robot-assisted-radical-cystectomy-an-initial-experience
#35
JOURNAL ARTICLE
Takahiro Inoue, Manabu Kato, Takeshi Sasaki, Yusuke Sugino, Shunsuke Owa, Taketomo Nishikawa, Momoko Kato, Shinichiro Higashi, Satoru Masui, Kouhei Nishikawa
BACKGROUND: Robot-assisted radical cystectomy (RARC) with urinary diversion has become a standard surgical procedure because of its three-dimensional high-definition surgical field of view, flexibility, and stability. However, because of the highly complex steps of surgery, postoperative complications cannot be ignored. METHODS: This retrospective, single-center, observational cohort study investigated the postoperative complications following RARC at a non-high-volume center in Japan...
January 31, 2024: Translational Cancer Research
https://read.qxmd.com/read/38410228/first-case-report-of-robot-assisted-radical-cystectomy-and-intracorporeal-urinary-diversion-using-the-hinotori-surgical-robot-system
#36
Tetsutaro Hayashi, Hiroyuki Kitano, Keisuke Hieda, Nobuyuki Hinata
BACKGROUND: The field of robotic surgery is still continuously advancing, with several cutting-edge robotic systems currently under development. This study aimed to present the methodology and perioperative outcomes of robot-assisted radical cystectomy (RARC) and intracorporeal urinary diversion (ICUD) in patient with muscle invasive bladder cancer (MIBC) by utilizing the hinotori Surgical Robot System, a recently developed robot-assisted surgical platform. CASE DESCRIPTION: A 79-year-old man with MIBC, cT2N0M0, received RARC and ICUD after two courses of neoadjuvant chemotherapy...
January 31, 2024: Translational Cancer Research
https://read.qxmd.com/read/38410226/current-status-of-robot-assisted-total-pelvic-exenteration-focusing-on-the-field-of-urology-a-clinical-practice-review
#37
REVIEW
Jun Kamei, Tetsuya Fujimura
Total pelvic exenteration (TPE) is a highly invasive surgery associated with high rates of perioperative morbidity and mortality and is commonly performed for several types of locally advanced or recurrent pelvic cancers. It involves multivisceral resection, including the rectum, sigmoid colon, bladder, prostate, uterus, vagina, or ovaries, and urologists normally perform radical cystectomy or radical prostatectomy and urinary diversion in collaboration with colorectal surgeons and gynecologists. In the urological field, robot-assisted surgeries have been widely performed as one of the main minimally invasive procedures because of their superior perioperative or oncological outcomes compared to open or laparoscopic surgeries...
January 31, 2024: Translational Cancer Research
https://read.qxmd.com/read/38398151/diagnostic-value-of-urine-cytology-in-pharmacologically-forced-diuresis-for-upper-tract-urothelial-carcinoma-diagnosis-and-follow-up
#38
JOURNAL ARTICLE
Nicola Giudici, Jennifer Blarer, Niranjan Sathianathen, Fiona C Burkhard, Patrick Y Wuethrich, George N Thalmann, Roland Seiler, Marc A Furrer
We performed a urine cytology analysis of a pharmacologically induced diuresis for the diagnosis of upper tract urothelial carcinoma. To evaluate the diagnostic value of cytology of pharmacologically forced diuresis, an initial cohort of 77 consecutive patients with primary upper tract urothelial carcinoma treated via radical surgery was enrolled. To evaluate pharmacologically forced diuresis cytology as a follow-up procedure, a second cohort of 1250 patients who underwent a radical cystectomy for bladder cancer was selected...
February 12, 2024: Cancers
https://read.qxmd.com/read/38392645/impacts-of-neoadjuvant-chemotherapy-on-perioperative-outcomes-in-patients-with-bladder-cancer-treated-with-radical-cystectomy-a-single-high-volume-center-experience
#39
JOURNAL ARTICLE
Flavia Proietti, Rocco Simone Flammia, Leslie Claire Licari, Eugenio Bologna, Alfredo Maria Bove, Aldo Brassetti, Gabriele Tuderti, Riccardo Mastroianni, Antonio Tufano, Giuseppe Simone, Costantino Leonardo
(1) Background: Less than 30% of patients with muscle-invasive bladder cancer (MIBC) receive neoadjuvant chemotherapy (NAC), and reasons for underuse remain unclear. One potential explanation is the concern for the increased risk of perioperative morbidity and mortality. The aim of this study is to investigate the impact of NAC on the risk of detrimental perioperative outcomes in patients with MIBC treated with radical cystectomy (RC). (2) Methods: We identified patients receiving RC for MIBC (T2-4a N0 M0) from 2016 to 2022...
February 16, 2024: Journal of Personalized Medicine
https://read.qxmd.com/read/38386794/applicability-and-feasibility-of-robot-assisted-cystectomy-and-intracorporeal-urinary-diversion-in-a-patient-with-right-renal-pelvic-ectopia
#40
Stefano Puliatti, Stefania Ferretti, Natali Rodriguez Peñaranda, Ahmed Eissa, Marco Ticonosco, Andrea De Faveri, Cosimo De Carne, Pawel Wisz, Riccardo Ferrari, Greta Tosi, Filippo Annino, Giampaolo Bianchi, Salvatore Micali
BACKGROUND: The ectopic pelvic kidney, a common renal anomaly, is often smaller and malformed, with a shorter and sometimes tortuous ureter (1). Muscle-invasive bladder cancer (MIBC), constituting 15-25% of bladder cancer cases (2), mandates radical cystectomy with a 50% 5-year survival rate (2). Despite the growing use of robot-assisted radical cystectomy (RARC) (3, 4), there is limited data on its application in ectopic kidneys. Only one RARC case has been reported (5), in contrast to numerous open radical cystectomies (1, 6) involving an ectopic kidney...
2024: International Braz J Urol: Official Journal of the Brazilian Society of Urology
keyword
keyword
170116
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.